東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/18 | 2,950 | 2,975 | 2,929 | 2,958 | +31 | +1.1% | 56,200 |
| 2024/09/17 | 2,966 | 3,000 | 2,902 | 2,927 | -1 | ±0% | 67,400 |
| 2024/09/13 | 2,970 | 2,970 | 2,923 | 2,928 | -53 | -1.8% | 81,800 |
| 2024/09/12 | 2,922 | 2,994 | 2,920 | 2,981 | +90 | +3.1% | 81,400 |
| 2024/09/11 | 2,889 | 2,913 | 2,866 | 2,891 | -29 | -1% | 120,600 |
| 2024/09/10 | 2,929 | 2,949 | 2,909 | 2,920 | -1 | ±0% | 83,300 |
| 2024/09/09 | 2,881 | 2,925 | 2,834 | 2,921 | -29 | -1% | 115,600 |
| 2024/09/06 | 2,978 | 3,000 | 2,935 | 2,950 | -13 | -0.4% | 64,800 |
| 2024/09/05 | 2,975 | 2,995 | 2,940 | 2,963 | +38 | +1.3% | 57,000 |
| 2024/09/04 | 2,901 | 2,976 | 2,901 | 2,925 | -60 | -2% | 63,400 |
| 2024/09/03 | 2,920 | 2,989 | 2,920 | 2,985 | +81 | +2.8% | 78,800 |
| 2024/09/02 | 2,940 | 2,940 | 2,876 | 2,904 | -21 | -0.7% | 50,800 |
| 2024/08/30 | 2,916 | 2,939 | 2,916 | 2,925 | +7 | +0.2% | 47,500 |
| 2024/08/29 | 2,890 | 2,928 | 2,887 | 2,918 | +27 | +0.9% | 49,300 |
| 2024/08/28 | 2,856 | 2,903 | 2,854 | 2,891 | +18 | +0.6% | 36,200 |
| 2024/08/27 | 2,843 | 2,884 | 2,843 | 2,873 | +23 | +0.8% | 56,600 |
| 2024/08/26 | 2,831 | 2,863 | 2,816 | 2,850 | +1 | ±0% | 60,600 |
| 2024/08/23 | 2,839 | 2,854 | 2,812 | 2,849 | +49 | +1.8% | 89,500 |
| 2024/08/22 | 2,799 | 2,815 | 2,779 | 2,800 | -11 | -0.4% | 38,000 |
| 2024/08/21 | 2,765 | 2,818 | 2,765 | 2,811 | +8 | +0.3% | 51,600 |
| 2024/08/20 | 2,773 | 2,815 | 2,767 | 2,803 | +23 | +0.8% | 74,400 |
| 2024/08/19 | 2,810 | 2,817 | 2,765 | 2,780 | -47 | -1.7% | 57,100 |
| 2024/08/16 | 2,828 | 2,838 | 2,805 | 2,827 | +49 | +1.8% | 81,500 |
| 2024/08/15 | 2,810 | 2,822 | 2,740 | 2,778 | +4 | +0.1% | 103,300 |
| 2024/08/14 | 2,728 | 2,840 | 2,728 | 2,774 | +46 | +1.7% | 155,300 |
| 2024/08/13 | 2,670 | 2,740 | 2,637 | 2,728 | +70 | +2.6% | 210,900 |
| 2024/08/09 | 2,706 | 2,847 | 2,609 | 2,658 | +121 | +4.8% | 326,400 |
| 2024/08/08 | 2,530 | 2,594 | 2,519 | 2,537 | -40 | -1.6% | 170,400 |
| 2024/08/07 | 2,493 | 2,659 | 2,493 | 2,577 | -13 | -0.5% | 164,500 |
| 2024/08/06 | 2,596 | 2,701 | 2,565 | 2,590 | +33 | +1.3% | 124,800 |
| 2024/08/05 | 2,621 | 2,680 | 2,488 | 2,557 | -214 | -7.7% | 203,500 |
| 2024/08/02 | 2,780 | 2,844 | 2,721 | 2,771 | -109 | -3.8% | 152,600 |
| 2024/08/01 | 3,040 | 3,040 | 2,870 | 2,880 | -185 | -6% | 103,400 |
| 2024/07/31 | 2,992 | 3,070 | 2,991 | 3,065 | +73 | +2.4% | 78,900 |
| 2024/07/30 | 3,035 | 3,040 | 2,962 | 2,992 | -38 | -1.3% | 76,800 |
| 2024/07/29 | 2,995 | 3,065 | 2,981 | 3,030 | +35 | +1.2% | 64,400 |
| 2024/07/26 | 3,035 | 3,035 | 2,987 | 2,995 | -35 | -1.2% | 59,000 |
| 2024/07/25 | 3,030 | 3,045 | 2,988 | 3,030 | -15 | -0.5% | 107,600 |
| 2024/07/24 | 3,050 | 3,065 | 3,025 | 3,045 | -10 | -0.3% | 53,900 |
| 2024/07/23 | 3,045 | 3,070 | 3,035 | 3,055 | +20 | +0.7% | 30,400 |
| 2024/07/22 | 3,065 | 3,070 | 3,020 | 3,035 | -20 | -0.7% | 59,500 |
| 2024/07/19 | 3,060 | 3,065 | 3,000 | 3,055 | -20 | -0.7% | 70,800 |
| 2024/07/18 | 3,045 | 3,090 | 3,015 | 3,075 | +15 | +0.5% | 68,600 |
| 2024/07/17 | 3,060 | 3,090 | 3,045 | 3,060 | +25 | +0.8% | 79,500 |
| 2024/07/16 | 3,080 | 3,100 | 3,015 | 3,035 | -20 | -0.7% | 94,600 |
| 2024/07/12 | 3,080 | 3,100 | 3,020 | 3,055 | -30 | -1% | 126,000 |
| 2024/07/11 | 3,030 | 3,085 | 3,010 | 3,085 | +87 | +2.9% | 96,500 |
| 2024/07/10 | 2,992 | 3,050 | 2,972 | 2,998 | +6 | +0.2% | 88,300 |
| 2024/07/09 | 2,947 | 2,999 | 2,924 | 2,992 | +48 | +1.6% | 96,100 |
| 2024/07/08 | 2,958 | 2,979 | 2,925 | 2,944 | -5 | -0.2% | 75,600 |
151～
200
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
